BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16712696)

  • 1. Craniofacial malformations: intrinsic vs extrinsic neural crest cell defects in Treacher Collins and 22q11 deletion syndromes.
    Walker MB; Trainor PA
    Clin Genet; 2006 Jun; 69(6):471-9. PubMed ID: 16712696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neural crest: a versatile organ system.
    Zhang D; Ighaniyan S; Stathopoulos L; Rollo B; Landman K; Hutson J; Newgreen D
    Birth Defects Res C Embryo Today; 2014 Sep; 102(3):275-98. PubMed ID: 25227568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniofacial development: the tissue and molecular interactions that control development of the head.
    Francis-West PH; Robson L; Evans DJ
    Adv Anat Embryol Cell Biol; 2003; 169():III-VI, 1-138. PubMed ID: 12793205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.
    Terrazas K; Dixon J; Trainor PA; Dixon MJ
    Wiley Interdiscip Rev Dev Biol; 2017 May; 6(3):. PubMed ID: 28186364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
    Noack Watt KE; Achilleos A; Neben CL; Merrill AE; Trainor PA
    PLoS Genet; 2016 Jul; 12(7):e1006187. PubMed ID: 27448281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocristopathies: Enigmatic Appearances of Neural Crest Cell-derived Abnormalities.
    Sato TS; Handa A; Priya S; Watal P; Becker RM; Sato Y
    Radiographics; 2019; 39(7):2085-2102. PubMed ID: 31697622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome.
    Frank DU; Fotheringham LK; Brewer JA; Muglia LJ; Tristani-Firouzi M; Capecchi MR; Moon AM
    Development; 2002 Oct; 129(19):4591-603. PubMed ID: 12223415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome.
    van Gijn DR; Tucker AS; Cobourne MT
    Br J Oral Maxillofac Surg; 2013 Jul; 51(5):384-8. PubMed ID: 23036831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.
    Sakai D; Trainor PA
    Dev Growth Differ; 2016 Sep; 58(7):577-85. PubMed ID: 27481486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treacher Collins syndrome.
    Dixon J; Trainor P; Dixon MJ
    Orthod Craniofac Res; 2007 May; 10(2):88-95. PubMed ID: 17552945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome.
    Yamagishi H; Srivastava D
    Trends Mol Med; 2003 Sep; 9(9):383-9. PubMed ID: 13129704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.
    Dixon J; Brakebusch C; Fässler R; Dixon MJ
    Hum Mol Genet; 2000 Jun; 9(10):1473-80. PubMed ID: 10888597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial dysostoses: Etiology, pathogenesis and management.
    Trainor PA; Andrews BT
    Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):283-94. PubMed ID: 24123981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
    Sanchez E; Laplace-Builhé B; Mau-Them FT; Richard E; Goldenberg A; Toler TL; Guignard T; Gatinois V; Vincent M; Blanchet C; Boland A; Bihoreau MT; Deleuze JF; Olaso R; Nephi W; Lüdecke HJ; Verheij JBGM; Moreau-Lenoir F; Denoyelle F; Rivière JB; Laplanche JL; Willing M; Captier G; Apparailly F; Wieczorek D; Collet C; Djouad F; Geneviève D
    Genet Med; 2020 Mar; 22(3):547-556. PubMed ID: 31649276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
    Sakai D; Dixon J; Achilleos A; Dixon M; Trainor PA
    Nat Commun; 2016 Jan; 7():10328. PubMed ID: 26792133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.
    Trainor PA
    Am J Med Genet A; 2010 Dec; 152A(12):2984-94. PubMed ID: 20734335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
    Sakai D; Trainor PA
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making headway: the roles of Hox genes and neural crest cells in craniofacial development.
    Trainor PA
    ScientificWorldJournal; 2003 Apr; 3():240-64. PubMed ID: 12806110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.